Chemoinformaics analysis of 24-ethyl-5alpha-cholesta-7
| Molecular Weight | 202.341 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 11 |
| Exact Molecular Weight | 202.172 | nRing | 2 |
| Solubility: LogS | -5.954 | nHRing | 0 |
| Solubility: LogP | 5.166 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 39.7194 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.622 |
| Synth | 3.126 |
| Natural Product Likeliness | 1.021 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.502 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.508 |
| MDCK | 0.0000141 |
| BBB | 0.562 |
| PPB | 0.978034 |
| VDSS | 2.946 |
| FU | 0.0282398 |
| CYP1A2-inh | 0.384 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.634 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.494 |
| CYP2c9-sub | 0.864 |
| CYP2d6-inh | 0.09 |
| CYP2d6-sub | 0.854 |
| CYP3a4-inh | 0.47 |
| CYP3a4-sub | 0.794 |
| CL | 7.286 |
| T12 | 0.069 |
| hERG | 0.046 |
| Ames | 0.216 |
| ROA | 0.175 |
| SkinSen | 0.067 |
| Carcinogencity | 0.147 |
| EI | 0.669 |
| Respiratory | 0.112 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.805098 |